U.S. markets close in 2 hours 7 minutes
  • S&P 500

    3,848.02
    -22.27 (-0.58%)
     
  • Dow 30

    31,468.20
    +76.68 (+0.24%)
     
  • Nasdaq

    13,112.50
    -246.29 (-1.84%)
     
  • Russell 2000

    2,244.81
    +13.30 (+0.60%)
     
  • Crude Oil

    61.67
    +1.92 (+3.21%)
     
  • Gold

    1,717.10
    -16.50 (-0.95%)
     
  • Silver

    26.41
    -0.47 (-1.74%)
     
  • EUR/USD

    1.2079
    -0.0009 (-0.07%)
     
  • 10-Yr Bond

    1.4690
    +0.0540 (+3.82%)
     
  • GBP/USD

    1.3976
    +0.0019 (+0.14%)
     
  • USD/JPY

    106.9600
    +0.2500 (+0.23%)
     
  • BTC-USD

    51,209.51
    +3,391.44 (+7.09%)
     
  • CMC Crypto 200

    1,025.10
    +37.01 (+3.75%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Ultivue to Participate in Cowen’s 41st Annual Health Care Conference

·1 min read

Ultivue, an industry leader in multiplexing for tissue biomarker analysis, will participate in Cowen’s 41st Annual Health Care Conference, a virtual event taking place March 1-4, 2021. The conference incorporates presentations, fireside chats, and innovative panel discussions hosted by members of the Cowen research team that focus on various aspects of the health care industry.

Ultivue’s President and Chief Executive Officer, Jacques Corriveau, will host a series fireside chats, designed as one-on-one meetings with interested investors, on Tuesday, March 2nd.

About Ultivue

Ultivue provides researchers in translational medicine with multiplex biomarker assays for tissue phenotyping and digital pathology. Its proprietary InSituPlex technology enables advanced exploration and interrogation of tissue samples for precision medicine research. These highly customizable solutions and scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs. Learn more at Ultivue.com.

About Cowen

Cowen Inc. ("Cowen" or the "Company") is a diversified financial services firm offering investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services and actively managed alternative investment products. Cowen focuses on delivering value-added capabilities to our clients in order to help them outperform. Founded in 1918, the Company is headquartered in New York and has offices worldwide. Learn more at Cowen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210211005909/en/

Contacts

Christopher Hynes
Ultivue
christopher.hynes@ultivue.com